Skip to main content
. 2008 Jul 16;2008(3):CD006297. doi: 10.1002/14651858.CD006297.pub2

Comparison 8. Sensitivity analysis.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 Glycated haemoglobin‐ large trials ommited 20 5300 Mean Difference (IV, Fixed, 95% CI) ‐0.08 [‐0.12, ‐0.03]
1.1 Short term 3 640 Mean Difference (IV, Fixed, 95% CI) ‐0.08 [‐0.18, 0.02]
1.2 Intermediate term 9 2105 Mean Difference (IV, Fixed, 95% CI) ‐0.18 [‐0.25, ‐0.10]
1.3 Long term 8 2555 Mean Difference (IV, Fixed, 95% CI) 0.03 [‐0.05, 0.11]
2 Glycated haemoglobin‐ low quality ommited 16 6267 Mean Difference (IV, Fixed, 95% CI) ‐0.05 [‐0.10, ‐0.01]
2.1 Short term 2 875 Mean Difference (IV, Fixed, 95% CI) ‐0.04 [‐0.13, 0.06]
2.2 Intermediate term 8 2560 Mean Difference (IV, Fixed, 95% CI) ‐0.16 [‐0.23, ‐0.08]
2.3 Long term 7 2832 Mean Difference (IV, Fixed, 95% CI) 0.04 [‐0.03, 0.12]
3 Fasting blood glucose‐total‐ low quality ommited 13 4559 Mean Difference (IV, Fixed, 95% CI) ‐0.75 [‐0.91, ‐0.60]
4 Fasting plasma glucose‐ total‐ low quality ommited 9 4485 Mean Difference (IV, Fixed, 95% CI) ‐1.07 [‐1.36, ‐0.79]
5 Mean daily self measured blood glucose (SMBG) average (7‐8 points)‐ low quality ommited 3 500 Mean Difference (IV, Fixed, 95% CI) ‐0.09 [‐0.58, 0.40]
5.1 Short term 1 256 Mean Difference (IV, Fixed, 95% CI) 0.30 [‐0.42, 1.02]
5.2 Intermediate term 2 244 Mean Difference (IV, Fixed, 95% CI) ‐0.43 [‐1.09, 0.24]
5.3 Long term 0 0 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
6 Percent of participating experiencing hypoglycemia‐ low quality ommited 13   Odds Ratio (M‐H, Fixed, 95% CI) Subtotals only
6.1 Total episodes 12 5214 Odds Ratio (M‐H, Fixed, 95% CI) 0.92 [0.77, 1.09]
6.2 Severe episodes 10 4688 Odds Ratio (M‐H, Fixed, 95% CI) 0.71 [0.58, 0.88]
6.3 Nocturnal episodes 12 5070 Odds Ratio (M‐H, Fixed, 95% CI) 0.73 [0.64, 0.82]
7 Hypoglycemic events per 100 patient's days‐ low quality ommited 14   Mean Difference (IV, Fixed, 95% CI) Subtotals only
7.1 Total episodes 11 4301 Mean Difference (IV, Fixed, 95% CI) ‐0.70 [‐0.82, ‐0.58]
7.2 Severe episodes 10 4110 Mean Difference (IV, Fixed, 95% CI) 0.00 [‐0.02, 0.02]
7.3 Nocturnal episodes 12 4497 Mean Difference (IV, Fixed, 95% CI) ‐0.38 [‐0.44, ‐0.32]
8 Glycated haemoglobin‐ selection bias analysis 10 4077 Mean Difference (IV, Fixed, 95% CI) ‐0.12 [‐0.18, ‐0.07]
8.1 Short term 1 619 Mean Difference (IV, Fixed, 95% CI) ‐0.10 [‐0.27, 0.07]
8.2 Intermediate term 7 2405 Mean Difference (IV, Fixed, 95% CI) ‐0.19 [‐0.27, ‐0.12]
8.3 Long term 3 1053 Mean Difference (IV, Fixed, 95% CI) 0.02 [‐0.09, 0.14]
9 Fasting blood glucose‐total‐ selection bias analysis 7 2628 Mean Difference (IV, Fixed, 95% CI) ‐0.72 [‐0.93, ‐0.51]
10 Fasting plasma glucose‐ total‐ selection bias analysis 5 2632 Mean Difference (IV, Fixed, 95% CI) ‐0.92 [‐1.26, ‐0.58]
11 Mean daily self measured blood glucose (SMBG) average (7‐8 points)‐ selection bias analysis 3 365 Mean Difference (IV, Fixed, 95% CI) ‐0.47 [‐0.86, ‐0.09]
11.1 Intermediate term 2 244 Mean Difference (IV, Fixed, 95% CI) ‐0.43 [‐1.09, 0.24]
11.2 Long term 1 121 Mean Difference (IV, Fixed, 95% CI) ‐0.5 [‐0.98, ‐0.02]
12 Percent of participating experiencing hypoglycemia‐ selection bias analysis 9   Odds Ratio (M‐H, Fixed, 95% CI) Subtotals only
12.1 Total episodes 7 3093 Odds Ratio (M‐H, Fixed, 95% CI) 0.92 [0.73, 1.15]
12.2 Severe episodes 9 3326 Odds Ratio (M‐H, Fixed, 95% CI) 0.77 [0.61, 0.98]
12.3 Nocturnal episodes 7 3091 Odds Ratio (M‐H, Fixed, 95% CI) 0.74 [0.63, 0.86]
13 Hypoglycemic events per 100 patient's days‐ selection bias analysis 10   Mean Difference (IV, Fixed, 95% CI) Subtotals only
13.1 Total episodes 9 2873 Mean Difference (IV, Fixed, 95% CI) ‐1.82 [‐2.07, ‐1.56]
13.2 Severe episodes 9 2811 Mean Difference (IV, Fixed, 95% CI) 0.01 [‐0.01, 0.03]
13.3 Nocturnal episodes 8 2741 Mean Difference (IV, Fixed, 95% CI) ‐0.64 [‐0.74, ‐0.54]
14 Glycated haemoglobin‐ attrition bias analysis 11 3919 Mean Difference (IV, Fixed, 95% CI) ‐0.10 [‐0.17, ‐0.04]
14.1 Intermediate term 5 1672 Mean Difference (IV, Fixed, 95% CI) ‐0.22 [‐0.31, ‐0.13]
14.2 Long term 6 2247 Mean Difference (IV, Fixed, 95% CI) 0.01 [‐0.08, 0.11]
15 Fasting blood glucose‐total‐ attrition bias analysis 8 2830 Mean Difference (IV, Fixed, 95% CI) ‐0.73 [‐0.94, ‐0.51]
16 Fasting plasma glucose‐ total‐ attrition bias analysis 6 3025 Mean Difference (IV, Fixed, 95% CI) ‐0.98 [‐1.34, ‐0.63]
17 Mean daily self measured blood glucose (SMBG) average (7‐8 points)‐ attrition bias analysis 2 244 Mean Difference (IV, Fixed, 95% CI) ‐0.43 [‐1.09, 0.24]
17.1 Intermediate term 2 244 Mean Difference (IV, Fixed, 95% CI) ‐0.43 [‐1.09, 0.24]
18 Percent of participating experiencing hypoglycemia‐ attrition bias analysis 9   Odds Ratio (M‐H, Fixed, 95% CI) Subtotals only
18.1 Total episodes 8 3497 Odds Ratio (M‐H, Fixed, 95% CI) 0.79 [0.65, 0.97]
18.2 Severe episodes 8 3484 Odds Ratio (M‐H, Fixed, 95% CI) 0.68 [0.54, 0.87]
18.3 Nocturnal episodes 9 3609 Odds Ratio (M‐H, Fixed, 95% CI) 0.62 [0.53, 0.73]
19 Hypoglycemic events per 100 patient's days‐ attrition bias analysis 11   Mean Difference (IV, Fixed, 95% CI) Subtotals only
19.1 Total episodes 9 3425 Mean Difference (IV, Fixed, 95% CI) ‐0.70 [‐0.83, ‐0.58]
19.2 Severe episodes 9 3491 Mean Difference (IV, Fixed, 95% CI) ‐0.01 [‐0.03, 0.01]
19.3 Nocturnal episodes 9 3609 Mean Difference (IV, Fixed, 95% CI) ‐0.38 [‐0.44, ‐0.32]